3B BlackBio Dx Share Price

<h3><span style="font-size:16px;"><strong>Agrochemicals company 3B BlackBio Dx announced Q1FY27 results</strong></span></h3> <p _ngcontent-ng-c1940132427=""><strong _ngcontent-ng-c1940132427="">Consolidated Financial Highlights:</strong></p> <ul> <li _ngcontent-ng-c1940132427="">Revenue from operations for Q1FY27 was Rs 3,349.08 lakh, showing a 50.62% YoY increase compared to Rs 2,223.46 lakh in Q1FY26, and a 5.48% QoQ decline from Rs 3,543.41 lakh in Q4FY26.</li> <li _ngcontent-ng-c1940132427="">Total Income stood at Rs 3,963.38 lakh in Q1FY27, up 49.27% YoY from Rs 2,655.12 lakh in Q1FY26, but down 13.05% QoQ from Rs 4,558.29 lakh in Q4FY26.</li> <li _ngcontent-ng-c1940132427="">Profit before tax for the quarter was Rs 1,321.95 lakh, a decrease of 16.67% YoY from Rs 1,586.35 lakh in Q1FY26, and a 9.74% QoQ decrease from Rs 1,464.62 lakh in Q4FY26.</li> <li _ngcontent-ng-c1940132427="">Net Profit (attributable to owners of the parent) was Rs 953.19 lakh in Q1FY27, reflecting a 24.29% YoY decline from Rs 1,258.93 lakh in Q1FY26, and a marginal 0.24% QoQ decline from Rs 955.51 lakh in Q4FY26.</li> <li _ngcontent-ng-c1940132427="">Basic Earnings Per Share (EPS) for Q1FY27 was Rs 10.48, compared to Rs 14.76 in Q1FY26 and Rs 11.44 in Q4FY26.</li> </ul> <p><strong _ngcontent-ng-c1940132427="">Standalone Financial Highlights:</strong></p> <ul> <li _ngcontent-ng-c1940132427="">Revenue from operations stood at Rs 2,294.52 lakh in Q1FY27, representing a growth of 12.71% YoY compared to Rs 2,035.71 lakh in Q1FY26, and a decrease of 6.84% QoQ from Rs 2,463.01 lakh in Q4FY26.</li> <li _ngcontent-ng-c1940132427="">Total Income for the quarter was Rs 2,824.79 lakh, marking a 14.50% YoY increase from Rs 2,467.13 lakh in Q1FY26, and an 8.93% QoQ increase from Rs 2,593.34 lakh in Q4FY26.</li> <li _ngcontent-ng-c1940132427="">Profit before tax for Q1FY27 reached Rs 1,835.32 lakh, reflecting a 17.05% YoY growth compared to Rs 1,567.94 lakh in Q1FY26, and a significant 49.36% QoQ increase from Rs 1,228.79 lakh in Q4FY26.</li> <li _ngcontent-ng-c1940132427="">Net Profit for the quarter was Rs 1,411.21 lakh, an increase of 13.26% YoY from Rs 1,246.04 lakh in Q1FY26, and an 89.51% QoQ surge from Rs 744.65 lakh in Q4FY26.</li> <li _ngcontent-ng-c1940132427="">Basic Earnings Per Share (EPS) for Q1FY27 was Rs 16.47, compared to Rs 14.54 in Q1FY26 and Rs 8.69 in Q4FY26.</li> </ul> <p><strong _ngcontent-ng-c1940132427="">Business Highlights:</strong></p> <ul> <li _ngcontent-ng-c1940132427=""><strong _ngcontent-ng-c1940132427="">Segment Performance (Consolidated):</strong> <ul> <li _ngcontent-ng-c1940132427=""><strong _ngcontent-ng-c1940132427="">Diagnostic Kits:</strong> This segment contributed the bulk of consolidated revenue at Rs 3,205.74 lakh in Q1FY27, growing 60.60% YoY from Rs 1,996.06 lakh in Q1FY26. Segment profit before interest and tax was Rs 1,332.16 lakh.</li> <li _ngcontent-ng-c1940132427=""><strong _ngcontent-ng-c1940132427="">Agrochemicals:</strong> Revenue for this segment was Rs 143.34 lakh in Q1FY27, down from Rs 227.40 lakh in Q1FY26. Segment profit before interest and tax was Rs 0.03 lakh.</li> </ul> </li> <li _ngcontent-ng-c1940132427=""><strong _ngcontent-ng-c1940132427="">Operational Commentary:</strong> The company reported that the Agrochemical business is seasonal in nature and performance is impacted by weather conditions and cropping patterns.</li> <li _ngcontent-ng-c1940132427=""><strong _ngcontent-ng-c1940132427="">Expense Analysis:</strong> There was an increase in other expenses which the company attributed mainly to expenditure incurred towards the IVDR regulatory registration process and participation in an international trade fair.</li> <li _ngcontent-ng-c1940132427=""><strong _ngcontent-ng-c1940132427="">Consolidation:</strong> The consolidated results include the financials of 3B BlackBio Dx Limited (Holding), TRUPCR Europe Limited (Subsidiary), and Coris Holding, SRL, Belgium (Subsidiary).</li> </ul> <p><a class="lb" href="/get-document/post/pdf/5788061/" target="_blank">Result PDF</a></p>

• Trendlyne
• 3 days 17 hours ago

Newspaper Publication of Unaudited Financial Results for the quarter ended 30th June, 2026

• BSE India
• 3 days 18 hours ago

Investor''s Presentation

• BSE India
• 4 days 15 hours ago